More recently, we demonstrated that iNOS inhibition ameliorates parenchymal destruction and promotes reverse remodeling of the pulmonary vasculature, even in a severe model of elastase-induced emphysema, characterized by prominent parenchymal damage similar to the lesions found in lungs of end-stage COPD patients [11]. The gene discussed is NOS2; the disease is pulmonary emphysema.